Featured Article
Patient Experience of an 18F-FDG-PET/CT Examination: Need for Improvements in Patient Care

https://doi.org/10.1016/j.jradnu.2014.11.008Get rights and content

Highlights

  • Patient knowledge about the fluoro-deoxy-glucose positron emission tomography (PET)/computed tomography (CT) examination was low.

  • Patient satisfaction was high but communication needs to be improved.

  • Lower patient satisfaction correlates to a worse health-related quality of life.

  • The time spent in the PET/CT camera may be strenuous for the patient.

Abstract

The aims of this study were to investigate the patients' knowledge about and experience of an 18F-fluoro-deoxy-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) examination and to investigate the self-reported feelings of stress, level of physical activity, and health-related quality of life (HRQoL) and to find out if this was related to how they experienced the examination. A cross-sectional survey was used to collect information on 198 patients with known or suspected malignancy. As many as 32% to 63% were satisfied with the nursing staff, the communication, and the professional skills. Most patients did not know beforehand what an FDG-PET/CT examination was. The HRQoL, level of perceived stress, and physical activity were relatively low. A better HRQoL, lower level of perceived stress, and a higher level of physical activity were correlated to a more positive experience and higher education to more knowledge about the examination (p < .01–.05). The information before the examination needs to be improved. The results may be used to improve patient care and optimize imaging procedures.

Introduction

Molecular imaging in oncology has developed significantly in recent years. New hybrid imaging techniques are increasingly used whereby anatomical and functional imaging is combined in the same session. Positron emission tomography (PET) combined with computed tomography (CT), with the radioactively labeled glucose analog 18F-fluoro-deoxy-glucose (FDG), constitutes a standardized examination tool in clinical routine, especially used in cancer imaging for tumor staging, diagnosis of recurrent disease, monitoring of treatment response, and radiation therapy planning (Saif, Tzannou, Makrilia, & Syrigos, 2010).

The PET/CT examinations require planning and preparation on the part of both patients and nursing staff. Thus, it is important that patients are well informed and that the nursing staff is well trained. There are many studies on the imaging field of FDG-PET/CT for many types of cancer, but little is known about the patients' experiences in connection with a PET/CT examination. The patients' level of satisfaction may be an indicator of quality of care (Aiken et al., 2012, Charalambous, 2013). To our knowledge, so far, no studies have been published on this topic.

Patient satisfaction is a widely accepted dimension of quality care for several reasons: it may improve compliance to treatment regimens, it is an important outcome measure, and it has been described as a factor associated to improved health status (Aharony and Strasser, 1993, Fitzpatrick et al., 1998, Hall and Dornan, 1988). A meta-analysis of the concept of patient satisfaction showed several aspects, such as availability, overall quality, humaneness, professional skills, sufficient information, good facilities, and the staff's interest in psychosocial problems (Hall & Dornan, 1990).

The patient professional interaction is a necessity for patient satisfaction. It consists of several elements of which the patient's goals are important. Good communication should enable the care provider to meet the patient's expectations and culminate in a care relationship (Feldman-Stewart, Brundage, & Tishelman, 2005).

A number of studies have investigated patients' expectations and satisfaction in relation to other types of diagnostic examinations than PET/CT (Nightingale et al., 2012, Törnqvist et al., 2006). Törnqvist et al. (2006) concluded that patients needed to have confidence in the staff to feel secure during a magnetic resonance imaging (MRI) examination. Nightingale et al. (2012) found that written information before the examination was helpful, and on-going repeated explanations and reassurance were important to reduce patients' anxiety and distress during the examination procedure. Still, each individual patient has specific needs, and the nursing staff should be aware of their interaction with the patient and how it affects his/her ability to deal with the examination.

Furthermore, receiving information has been shown to reduce patients' anxiety and promote a positive attitude before undergoing an examination at a nuclear medicine department. Thus, the patient care provided by the nursing staff is fundamental to promoting patient satisfaction (Lledo et al., 1995). Cancer patients' needs, expectations, and experiences may also vary during the different stages of cancer treatment and management, and may depend on other factors such as age, gender, and educational status (Mistry, Wilson, Priestman, Damery, & Haque, 2010). According to Ollivier et al. (2009), most patients were (91–98%) in a radiology imaging department were generally satisfied with the care provided during ultrasound, mammography, CT, or MRI. However, 71% of the patients in this study would have appreciated additional information about the examination and some patients felt worried before the examination, and the reason for this was in most cases anxiety about the results.

The 18F-FDG-PET/CT requires that the patient has followed the given instructions beforehand and also staff members' instructions after arriving to the department (Boellaard et al., 2010). FDG is a glucose analog that reflects the increased metabolism in neoplastic viable and inflammatory cells (glycolytic pathway). Because the examination provides both anatomical (CT) and functional information (PET), there are rigorous pre-examination requirements. Patients must have fasted for at least 6 hours but with the intake of noncarbohydrate fluids to ensure adequate hydration. The blood glucose level should be 8.0 mmol/L or lower, corresponding to 150 to 200 mg/dL; and in patients with diabetes, the disease needs to be well controlled. It is important that documentation regarding relevant details in the patient history (recent surgery, inflammatory conditions, and treatments such as chemo or radiation therapy) is available. The FDG is injected intravenously, and during the subsequent 60-min uptake phase, the patient should be kept warm and remain silent and relaxed. The patient is also asked to drink water during this period and empty the urinary bladder immediately before the PET/CT examination. The patient is shown into the examination room and is positioned supine on the couch of the PET/CT scanner with the arms elevated over his/her head. It is important that the patient remains in the same position during the entire examination procedure to avoid image artifacts. The total time from the patient's arrival at the nuclear medicine department to his/her departure is approximately 2-3 hours, including a 30-min PET/CT examination time (Boellaard et al., 2010).

According to Romero, Vivas-Consuelo, and Alvis-Guzman (2013), health-related quality of life (HRQoL) is a concept that has a wide variety of definitions. Still, there is an evidence-based perception that has its focus on the individual's well-being. The HRQoL is also a useful indicator to measure health and disease. The HRQoL relates to how disease affects patients' well-being or patients' perceived quality of life (QoL; Ashing-Giwa, 2005). Cancer diagnosis is a traumatic experience that may affect different aspects of the patients' life, such as physiological well-being and the ability to physical activity. Karabulu, Erci, Ozer, and Ozdemir (2010) studied the prevalence and severity of symptoms in patients with cancer and found that the most common symptoms were fatigue, difficulty to remember, sadness, loss of appetite, lack of enjoyment of life, pain, distress, difficulty to walk, and dry mouth. Rustad, David, and Currier (2012) found that cancer patients and survivors have an increased risk to develop posttraumatic stress disorder in comparison with the general population, which could negatively affect the outcome of the treatment. Physical activity has proven to have health benefits across many diseases, including cancer (Broderick, Ryan, O'Donnell, & Hussey, 2014). Mishra et al. (2012) found that physical activity or exercise interventions improves cancer patients' HRQoL when it is given at the same time as the patients undergo cancer treatment and also reduces anxiety with breast cancer patients.

Because the 18F-FDG-PET/CT examination is dependent on the patient's cooperation and the procedure may be experienced as cumbersome, it would be interesting to evaluate the patient experience of the PET/CT examination and also the characteristics of the population remitted to the examination, such as physical activity, level of perceived stress, and experienced HRQoL. The desirable consequences of this study should be high patient satisfaction and patient care in nuclear medicine departments. The aims of the study were to investigate the patients' knowledge about and experience of the 18F-FDG-PET/CT examination. An additional aim was to investigate the self-reported feelings of perceived stress, the level of physical activity, and the experienced HRQoL and to find out if this was related to how the patients experienced the examination.

Section snippets

Participants

A consecutive sample of 198 patients (106 men and 92 women) who were scheduled for a standard 18F-FDG-PET/CT examination were asked to participate in the study during October 2011 and April 2012. Criteria for inclusion were 18 years or older, fluent in Swedish, reason for referral known or suspected malignancy, and scheduled for 18F-FDG-PET/CT examination for the first time. Criteria for exclusion were inability to understand Swedish; younger than 18 years of age; or if another protocol than

Participants

About 9 of 198 patients declined to participate and 189 patients accepted to participate in the study. Of these, 20 participants completed the questionnaire at the nuclear medicine department, whereas169 chose to take it home and return it by post. A reminder and a copy of the questionnaire were sent to 44 of the participants who had not replied by post within 3 weeks. Around 20 patients did not return the questionnaire. The response rate was 89% or 169 participants, 90 men and 79 women. The

Discussion

To our knowledge, this is the first study on this topic. The main findings were that most patients did not know beforehand what an FDG-PET/CT examination was or how it was conducted. More educated patients reported a higher knowledge about the examination. Most patients were to a very high degree satisfied with the interaction with the nursing staff and their professional skills. However, it may be a goal to increase this figure even further. The results also show that the patients were less

Conclusion

Only a small percentage of the participants knew what the FDG-PET/CT examination was or how it was conducted. Consequently, the information given to patients before the examination needs to be improved. Most of the participants were satisfied with the care provided by the nursing staff, the interaction, and the staff's professional skills, although some of the patients did not think that the nursing staff communicated in an understandable way. The nursing staff who carry out the FDG-PET/CT

Camilla Andersson, BSc, RN, is a radiographer, Section of Nuclear Medicine and PET, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

References (29)

  • R. Boellaard et al.

    FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

    European Journal of Nuclear Medicine and Molecular Imaging

    (2010)
  • J.M. Broderick et al.

    A guide to assessing physical activity using accelerometry in cancer patients

    Supportive Care in Cancer

    (2014)
  • P.M. Fayers et al.

    The EORTC QLQ-C30 Scoring Maual

    (2001)
  • D. Feldman-Stewart et al.

    A conceptual framework for patient-professional communication: an application to the cancer context

    Psychooncology

    (2005)
  • Cited by (9)

    • Anxiety experienced by oncological patients who undergo <sup>18</sup>F-FDG PET CT: A systematic review

      2021, Radiography
      Citation Excerpt :

      The lack of information about the 18F-FDG PET/CT procedure leads many patients to search for information independently on the internet. Often, patients face technical nature information, challenging to understand and focuses on the examination's threatening aspects.38–40 These results are consistent with another PET/CT study13 not included in the present review.13

    • It's a question of endurance – Patients with head and neck cancer experiences of <sup>18</sup>F-FDG PET/CT in a fixation mask

      2017, European Journal of Oncology Nursing
      Citation Excerpt :

      Our earlier investigations of patients' experiences and satisfaction of PET/CT examinations indicate that patients' knowledge regarding the examination procedure needs to be improved and increased. Time spent in the PET/CT scanner may also be strenuous because the patient must remain stationary in a fixed position during acquisition, thus increasing patient discomfort (Andersson et al., 2015, 2016). According to a recent study, 28% of the participants felt claustrophobic in varying degrees during the time spent in the PET/CT scanner (Andersson et al., 2015).

    View all citing articles on Scopus

    Camilla Andersson, BSc, RN, is a radiographer, Section of Nuclear Medicine and PET, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

    Cecilia Wassberg, MD, PhD, is a physician, Section of Nuclear Medicine and PET, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

    Birgitta Johansson, PhD, RN, is a senior lecturer, Section of Oncology, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

    Silvia Johansson, MD, PhD, is a physician, Section of Oncology, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

    Håkan Ahlström, MD, PhD, is a Professor, Section of Radiology, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden.

    Björn Wikehult, PhD, RN, is a senior lecturer, Education in Nursing, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

    Funding statement: This research received no specific grant from any funding agency in the public, commercial, or non-for-profit sectors.

    Conflict of Interest Statement: No conflict of interest has been declared by the authors.

    View full text